PRQR ProQR Therapeutics N.V. gains 153% Sep 25, 2018

Posted By: Rajesh Srivastava - Tuesday, September 25, 2018

Share

& Comment

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. The company's clinical stage candidates include QR-010, a RNA-based oligonucleotide that is in Phase Ib clinical trial for the treatment of cystic fibrosis. It also develops QR-110, which is in pre-clinical development stage for the treatment of Leber's congenital amaurosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.http://www.priceseries.com/trade/PRQR-ProQR-Therapeutics-NV-stock-gains-153-percent-a-Trade-Record-by-priceSeries-2018083120180925.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.